These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11168451)

  • 1. Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease.
    Müller B; Tsakiris DA; Roth CB; Guglielmetti M; Staub JJ; Marbet GA
    Eur J Clin Invest; 2001 Feb; 31(2):131-7. PubMed ID: 11168451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.
    Erem C; Ucuncu O; Yilmaz M; Kocak M; Nuhoglu I; Ersoz HO
    Endocrine; 2009 Feb; 35(1):75-80. PubMed ID: 18958631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood coagulation and fibrinolytic activity in hypothyroidism.
    Erem C; Kavgaci H; Ersöz HO; Hacihasanoglu A; Ukinç K; Karti SS; Deger O; Telatari M
    Int J Clin Pract; 2003 Mar; 57(2):78-81. PubMed ID: 12661786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood coagulation and fibrinolysis in patients with hyperthyroidism.
    Erem C; Ersoz HO; Karti SS; Ukinç K; Hacihasanoglu A; Değer O; Telatar M
    J Endocrinol Invest; 2002 Apr; 25(4):345-50. PubMed ID: 12030606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
    De Pergola G; De Mitrio V; Sciaraffia M; Pannacciulli N; Minenna A; Giorgino F; Petronelli M; Laudadio E; Giorgino R
    Metabolism; 1997 Nov; 46(11):1287-93. PubMed ID: 9361687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the respective influence of thyroid hormones and TSH on blood coagulation parameters after total thyroidectomy.
    Yango J; Alexopoulou O; Eeckhoudt S; Hermans C; Daumerie C
    Eur J Endocrinol; 2011 Apr; 164(4):599-603. PubMed ID: 21257724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of levothyroxine replacement therapy on coagulation and fibrinolysis in severe hypothyroidism.
    Chadarevian R; Jublanc C; Bruckert E; Giral P; Ankri A; Leenhardt L; Chapman J; Turpin G
    J Endocrinol Invest; 2005 May; 28(5):398-404. PubMed ID: 16075920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease.
    Ossei-Gerning N; Wilson IJ; Grant PJ
    Thromb Haemost; 1998 Apr; 79(4):736-40. PubMed ID: 9569183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism.
    Cantürk Z; Cetinarslan B; Tarkun I; Cantürk NZ; Ozden M; Duman C
    Thyroid; 2003 Oct; 13(10):971-7. PubMed ID: 14611707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis.
    Raffa S; Reverter JC; Seijo S; Tassies D; Abraldes JG; Bosch J; García-Pagán JC
    Clin Gastroenterol Hepatol; 2012 Jan; 10(1):72-8. PubMed ID: 21946303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Change of tissue factor pathway ratio during attack in patients with acute myocardial infarction and its clinical significance].
    Wang R; Wen BZ; Ma YT; Peng -; Li H; Zhong D; Li L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):198-202. PubMed ID: 19236778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood coagulation system in patients with chronic kidney disease: a prospective observational study.
    Huang MJ; Wei RB; Wang Y; Su TY; Di P; Li QP; Yang X; Li P; Chen XM
    BMJ Open; 2017 Jun; 7(5):e014294. PubMed ID: 28576889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between haemostatic variables and the presence or the extent of coronary atherosclerosis.
    Schmitz-Huebner U; Thompson SG; Balleisen L; Fechtrup C; Grosse-Heitmeyer W; Kirchhof B; Most E; Müller US; Seiffert C; Seiffert D
    Br Heart J; 1988 Mar; 59(3):287-91. PubMed ID: 3258521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.
    Carmassi F; Morale M; Puccetti R; De Negri F; Monzani F; Navalesi R; Mariani G
    Thromb Res; 1992 Sep; 67(6):643-54. PubMed ID: 1440530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of tissue factor and other hemostatic profiles in experimental hypothyroidism.
    Alturfan AA; Alturfan EE; Dariyerli N; Zengin E; Aytac E; Yigit G; Kokoglu E
    Endocrine; 2006 Aug; 30(1):63-7. PubMed ID: 17185793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues.
    Staub JJ; Althaus BU; Engler H; Ryff AS; Trabucco P; Marquardt K; Burckhardt D; Girard J; Weintraub BD
    Am J Med; 1992 Jun; 92(6):631-42. PubMed ID: 1605145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis.
    Vaziri ND; Gonzales EC; Wang J; Said S
    Am J Kidney Dis; 1994 Jun; 23(6):828-35. PubMed ID: 8203365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism.
    Gullu S; Sav H; Kamel N
    Eur J Endocrinol; 2005 Mar; 152(3):355-61. PubMed ID: 15757851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.